Allogene Therapeutics Reports First Quarter 2024 Financial Results and Business Update

Go back to Allogene Therapeutics Reports First Quarter 2024 Financial Results and Business Update
(NASDAQ: ALLO) Delayed: 1.99 +0.01 (0.51%)
Previous Close $1.98    52 Week High
Open $2.00    52 Week Low
Day High $2.01    P/E N/A 
Day Low $1.92    EPS
Volume 1,889,875